Ser597
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.7
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser597  -  DVL2 (human)

Site Information
RssGstRsDGGAGRT   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 22682200

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 2 ) , western blotting ( 2 )
Disease tissue studied:
bone cancer ( 2 ) , Ewing's sarcoma ( 2 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on biological processes:
cytoskeletal reorganization ( 2 ) , transcription, inhibited ( 2 )

References 

1

Nielsen CP, et al. (2019) USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification. Cell Rep 28, 1074-1089.e5
31340145   Curated Info

2

González-Sancho JM, et al. (2013) Functional Consequences of Wnt-induced Dishevelled 2 Phosphorylation in Canonical and Noncanonical Wnt Signaling. J Biol Chem 288, 9428-37
23396967   Curated Info